This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Amid an FDA overhaul and market volatility, one biotech executive says her publi...
The market turbulence unleashed by President Donald Trump’s tariff policies will...
The U.K. is rolling out new regulations meant to reduce red tape for clinical st...
The U.K. is rolling out new regulations meant to reduce red tape for clinical st...
J&J received a thumbs-up from the FDA last fall to launch human trials of the sy...
Ironwood Pharmaceuticals has been left considering its options after the FDA dem...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Third Harmonic Bio has abandoned plans to take its chronic spontaneous urticaria...
Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential...
Verve Therapeutics has generated evidence its PCSK9 pivot could pay off. One yea...
Verve Therapeutics has generated evidence its PCSK9 pivot could pay off. One yea...
The White House has ordered the National Institutes of Health to study regret an...
The White House has ordered the National Institutes of Health (NIH) to study reg...
The FDA announced on April 10 that the agency plans to end the requirement for n...
Currently under FDA review, Microbot’s miniaturized, disposable Liberty system i...
The market turbulence unleashed by President Donald Trump’s tariff policies will...
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and F...
After more than 13 years at Johnson & Johnson, including most recently serving a...
Kronos Bio is vacating its corporate headquarters in California amid a wider cos...
Discover how AI and RWD are transforming drug development by optimizing clinical...
CTI grew from a Cincinnati startup to a global leader in clinical research. CEO ...
More than 200 biotech leaders have penned a letter voicing concerns over the FDA...
The company’s SP SureForm 45 was green lit for use with its da Vinci SP system, ...
More than 200 biotech leaders have penned a letter voicing concerns over the FDA...